RSS-Feed abonnieren
DOI: 10.1055/s-2004-836026
New and Efficient Synthesis of 6,11-Dihydro-11-ethyl-5H-dibenz[b,e]azepine Derivatives Starting from N-Benzylanilines via Amino-Claisen and Friedel-Crafts Methodologies
Publikationsverlauf
Publikationsdatum:
25. November 2004 (online)
![](https://www.thieme-connect.de/media/synlett/200415/lookinside/thumbnails/10.1055-s-2004-836026-1.jpg)
Abstract
New and efficient synthesis of 6,11-dihydro-11-ethyl-5H-dibenz[b,e]azepine derivatives, using the key steps of BF3·OEt2-catalyzed aromatic amino-Claisen rearrangement and the intramolecular alkene Friedel-Crafts alkylation, is reported.
Key words
dibenz[b,e]azepine derivatives - amino-Claisen rearrangement - N-allylation - intramolecular alkene Friedel-Crafts alkylation
- 1
Briel D. Pharmazie 1990, 45: 895 - 2
Roeder T.Degen J.Gewecke M. Eur. J. Pharmacol. 1998, 349: 171 - 3
Sipido VK,Fernández-Gadea FJ,Andrés-Gil JI,Meert TF, andGil-Lopetegui P. inventors; PCT Int. Appl. WO 96 14320. ; Chem. Abstr. 1996, 125, 142705g - 4
Andrés JI.Alcázar J.Alonso JM.Díaz A.Fernández J.Gil P.Iturrino L.Matesanz E.Meert TF.Megens A.Sipido VK. Bioorg. Med. Chem. Lett. 2002, 12: 243 - 5
Andersen KE,Olsen UB,Andersen HS,Hohlweg R,Joergensen TK, andMadsen P. inventors; PCT Int. Appl. WO 96 31482. ; Chem. Abstr. 1997, 126, 8148v - 6
Joergensen TK,Andersen KE,Andersen HS,Hohlweg R,Madsen P, andOlsen UB. inventors; PCT Int. Appl. WO 96 31497. ; Chem. Abstr. 1997, 126, 8146t - 7
Brugnara C,Halperin J,Bellott EMJr,Froimowitz M,Lombardy RJ,Clifford JJ,Gao Y.-D,Haidar RM,Kelleher EW,Kher FM,Moussa AM,Sachdeva Y,Sun M,Taft HN,Lencer WI, andAlper S. inventors; PCT Int. Appl. WO 99 26628. ; Chem. Abstr. 1999, 131, 18936t - 8
Fukumi H,Sakamoto T,Sugiyama M,Iizuka Y, andYamaguchi T. inventors; U.S. US 5476848. ; Chem. Abstr. 1996, 124, 261063k - 9
Sinha AK.Nizamuddin S. Ind. J. Chem., Sect. B 1984, 23: 83 -
10a
Sasakura K.Sugasawa T. Heterocycles 1981, 15: 421 -
10b
Lypacewicz MK,Poslinska-Bucewka H,Smolinska J,Wasiak T,Sosinska D,Mostrak M,Trzpil B, andPaszkowski S. inventors; Pol. PL 175287. ; Chem. Abstr. 1999, 130, 296698x -
10c
Stappers F.Broeckx R.Leurs S.Van den Bergh L.Agten J.Lambrechts A.Van den Heurel D.De Smaele D. Org. Proc. Res. Develop. 2002, 6: 911 -
11a
Moriconi EJ.Maniscalco IA. J. Org. Chem. 1972, 37: 208 -
11b
Sinha AK.Nizamuddin S. Ind. J. Chem., Sect. B 1984, 23: 165 - 12
Kouznetsov V.Palma AR.Salas S.Vargas LY.Zubkov FI.Varlamov AV.Martínez JR. J. Heterocycl. Chem. 1997, 34: 1591 - 13
Palma AR.Rozo W.Stashenko E.Molina D.Kouznetsov V. J. Heterocycl. Chem. 1998, 35: 183 - 14
Kouznetsov V.Palma A.Rozo W.Stashenko E.Bahsas A.Amaro-Luis J. Tetrahedron Lett. 2000, 41: 6985 - 15
Varlamov A.Kouznetsov V.Zubkov F.Chernyshev A.Alexandrov G.Palma A.Vargas L.Salas S. Synthesis 2001, 849 - 16
Palma A.Salas S.Kouznetsov V.Stashenko E.Montenegro NG.Fontela GA. J. Heterocycl. Chem. 2001, 38: 837 - 17
Kouznetsov V.Palma A.Rozo W.Stashenko E.Bahsas A.Amaro-Luis J. Synth. Commun. 2002, 32: 2965 - 18
Baxter EW.Labaree D.Ammon HL.Mariano PS. J. Am. Chem. Soc. 1990, 112: 7682 - 19
Barta NS.Cook GR.Landis MS.Stille JR. J. Org. Chem. 1992, 57: 7188 - 20
Lai G.Anderson WK. Tetrahedron Lett. 1993, 34: 6849 - 21
Stroh R.Ebersberger J.Haberland H.Hahn W. Angew. Chem. 1957, 69: 124 - 22
Borch RF.Bernstein MD.Durst HD. J. Am. Chem. Soc. 1971, 93: 2897 - 23
Anderson WK.Lai G. Synthesis 1995, 1287
References
Spectral Data for Selected Compounds 3.
Compound 3b: 1H NMR (400 MHz, CDCl3): δ = 3.29 (2 H, d, J = 6.0 Hz, -CH2-), 4.10 (1 H, br s, NH), 4.34 (2 H, s, N-CH2-), 5.15 (2 H, m, =CH2), 5.95 (1 H, m, -CH=), 6.54 (1 H, d, J = 8.0 Hz, 6-H), 7.06 (1 H, d, J = 2.0 Hz, 3-H), 7.08 (1 H, dd, J = 8.0, 2.0 Hz, 5-H), 7.30-7.43 (5 H, m, H-phenyl). 13C NMR (100 MHz, CDCl3): δ = 36.1 (-CH2-), 48.2 (N-CH2-), 111.8 (6-C), 116.9 (=CH2), 122.0 (4-C), 125.2 (2-C), 127.3 (ortho-C), 127.4 (5-C), 128.7 (3-C), 129.0 (para-C), 129.5 (meta-C), 135.0 (-CH=), 139.0 (1′-C), 144.6 (1-C). MS (EI): m/z (%) = 257 (35Cl, 8) [M+], 242 (<1), 228 (1), 180 (11), 166 (26), 152 (11), 131 (40), 91 (100), 77 (10).
Compound 3c: 1H NMR (400 MHz, CDCl3): δ = 3.32 (2 H, d, J = 6.4 Hz, -CH2-), 4.06 (1 H, br s, NH), 4.34 (2 H, s, N-CH2-), 5.15 (2 H, m, =CH2), 5.97 (1 H, m, -CH=), 6.56 (1 H, dd, J = 9.0, 5.0 Hz, 6-H), 6.83 (1 H, d, J = 3.0 Hz, 3-H), 6.85 (1 H, dd, J = 9.0, 3.0 Hz, 5-H), 7.30-7.39 (5 H, m, H-phenyl). 13C NMR (100 MHz, CDCl3): δ = 36.2 (-CH2-), 48.7 (N-CH2-), 111.5 (d, J = 10.0 Hz. 6-C), 113.4 (d, J = 20.0 Hz, 3-C), 116.5 (d, J = 20.0 Hz, 5-C), 116.9 (=CH2), 125.3 (d, J = 10.0 Hz, 2-C), 127.2 (para-C), 127.5 (ortho-C), 128.5 (meta-C), 135.1 (-CH=), 139.3 (1′-C), 142.3 (1-C), 155.6 (d, J = 206.1 Hz, 4-C). MS (EI):
m/z (%) = 241 (28) [M+], 212 (8), 198 (4), 164 (9), 150 (66), 135 (17), 91 (100), 77 (6), 65 (21).
Compound 3d: 1H NMR (400 MHz, CDCl3): δ = 2.44 (3 H, s, 2-CH3), 3.29 (2 H, dt, J = 6.0, 1.6 Hz, -CH2-), 3.04 (1 H, br s, NH), 4.09 (2 H, s, N-CH2-), 5.05 (2 H, m, =CH2), 5.93 (1 H, m, -CH=), 6.95 (1 H, d, J = 8.0 Hz, 5-H), 7.07 (1 H, d, J = 8.0 Hz, 4-H), 7.33-7.40 (5 H, m, H-phenyl). 13C NMR (100 MHz, CDCl3): δ = 15.6 (2-CH3), 36.3 (-CH2-), 53.6 (N-CH2-), 116.9 (=CH2), 123.4 (4-C), 127.4 (ortho-C), 127.8 (5-C), 128.3 (para-C), 128.6 (meta-C), 129.4 (3-C), 130.4 (6-C), 133.7 (2-C), 136.5 (-CH=), 139.0 (1′-C), 147.4 (1-C). MS (EI): m/z (%) = 271 (35Cl, 11) [M+], 256 (2), 242 (4), 194 (7), 180 (33), 166 (18), 145 (46), 130 (14), 115 (8), 91 (100), 77 (8), 65 (22).
NMR and Analytical Data for Compounds 4.
Compound 4a: IR (KBr): 3405 cm-1. 1H NMR (400 MHz, CDCl3): δ = 0.91 (3 H, t, J = 7.4 Hz, 13-H), 2.17 (2 H, m, 12-H), 3.69 (1 H, t, J = 7.3 Hz, 11-H), 4.00 (1 H, d, J = 14.8 Hz, 6-HB), 4.95 (1 H, d, J = 14.8 Hz, 6-HA), 6.50 (1 H, d, J = 8.0 Hz, 4-H), 6.67 (1 H, td, J = 8.0, 1.0 Hz, 2-H), 6.96 (1 H, td, J = 8.0, 1.0 Hz, 3-H), 7.12 (1 H, dd, J = 8.0, 1.0 Hz, 1-H), 7.19-7.30 (4 H, m, 7-H-10-H). 13C NMR (100 MHz, CDCl3): δ = 13.0 (13-C), 31.6 (12-C), 51.1 (6-C), 54.8 (11-C), 117.9 (4-C), 118.2 (2-C), 127.2 (3-C), 127.6-129.5 (7-C-10-C), 130.2 (11a-C), 130.8 (1-C), 136.5 (6a-C), 142.1 (10a-C), 146.2 (4a-C). MS (EI): m/z (%) = 223 (14) [M+], 194 (100), 178 (8), 165 (11), 116 (10), 96 (10). Anal. Calcd for C16H17N: C, 86.06; H, 7.67; N, 6.27. Found: C, 86.13; H, 7.81; N, 6.14.
Compound 4b: IR (KBr): 3406 cm-1. 1H NMR (400 MHz, CDCl3): δ = 0.91 (3 H, t, J = 7.3 Hz, 13-H), 2.14 (2 H, m, 12-H), 3.63 (1 H, t, J = 7.7 Hz, 11-H), 4.17 (1 H, d, J = 14.4 Hz, 6-HB), 4.77 (1 H, d, J = 14.4 Hz, 6-HA), 6.40 (1 H, d, J = 8.5 Hz, 4-H), 6.91 (1 H, dd, J = 8.5, 2.3 Hz, 3-H), 7.10 (1 H, d, 2.3 Hz, 1-H), 7.12-7.34 (4 H, m, 7-H-10-H). 13C NMR (100 MHz, CDCl3): δ = 13.3 (13-C), 31.5 (12-C), 49.5 (6-C), 51.5 (11-C), 119.4 (4-C), 122.9 (2-C), 127.4 (3-C), 127.4-128.7 (7-C-10-C), 129.1 (11a-C), 130.7 (1-C), 136.5 (6a-C), 142.0 (10a-C), 145.1 (4a-C). MS (EI): m/z (%) = 257 (35Cl, 17) [M+], 228 (100), 193 (46), 165 (17), 115 (6), 89 (5). Anal. Calcd for C16H16ClN: C, 74.56; H, 6.26; N, 5.43. Found: C, 74.38; H, 6.49; N, 5.35.
Compound 4c: IR (KBr): 3429 cm-1. 1H NMR (400 MHz, CDCl3): δ = 0.91 (3 H, t, J = 7.1 Hz, 13-H), 2.18 (2 H, m, 12-H), 3.76 (1 H, t, J = 7.6 Hz, 11-H), 4.20 (1 H, d, J = 14.6 Hz, 6-HB), 4.71 (1 H, d, J = 14.6 Hz, 6-HA), 6.49 (1 H, dd, J = 8.0, 5.0 Hz, 4-H), 6.72 (1 H, ddd, J = 8.0, 3.0 Hz, 3-H), 6.82 (1 H, dd, J = 10.0, 3.0 Hz, 1-H), 7.13-7.22 (4 H, m, 7-H-10-H). 13C NMR (100 MHz, CDCl3): δ = 12.9 (13-C), 30.8 (12-C), 49.7 (6-C), 53.1 (11-C), 113.7 (d, J = 20 Hz, 3-C), 116.7 (d, J = 20 Hz, 1-C), 119.5 (d, J = 10 Hz, 4-C), 126.8 (8-C), 127.4 (9-C), 128.2 (7-C), 129.1 (10-C), 130.0 (11a-C), 136.5 (6a-C), 141.3 (10a-C), 142.5 (4a-C), 156.4 (d, J = 230 Hz, 2-C). MS (EI): m/z (%) = 241 (17) [M+], 212 (100), 196 (15), 183 (17), 165(10), 116 (9). Anal. Calcd for C16H16FN: C, 79.64; H, 6.68; N, 5.80.Found: C, 79.70; H, 6.80; N, 5.65.
Compound 4d: IR (KBr): 3446 cm-1. 1H NMR (400 MHz, CDCl3): δ = 0.96 (3 H, t, J = 7.4 Hz, 13-H), 2.20 (3 H, s, 4-CH3), 2.23 (2 H, m, 12-H), 3.84 (1 H, t, J = 7.6 Hz, 11-H), 4.09 (1 H, br s, N-H), 4.3 (1 H, d, J = 14.6 Hz, 6-HB), 4.90 (1 H, d, J = 14.6 Hz, 6-HA), 6.78 (1 H, d, J = 8.3 Hz, 2-H), 6.92 (1 H, d, J = 8.3 Hz, 1-H), 7.18-7.29 (4 H, m, 7-H-10-H). 13C NMR (100 MHz, CDCl3): δ = 11.9 (13-C), 13.3 (4-CH3), 29.9 (12-C), 48.0 (6-C), 52.5 (11-C), 117.5 (3-C), 120.3 (2-C), 124.9 (4-C), 125.9 (9-C), 126.5 (7-C), 127.0 (8-C), 127.7 (10-C), 127.8 (1-C), 131.8 (11a-C), 135.3 (6a-C), 140.9 (10a-C), 144.4 (4a-C). MS (EI): m/z (%) = 271 (35Cl, 13) [M+], 242 (100), 227 (6), 207 (31), 191 (10), 178 (11), 165 (8), 152 (6), 139 (2), 89 (4). Anal. Calcd for C17 H18ClN: C, 75.13; H, 6.68; N, 5.15. Found: C, 75.29; H, 6.83; N, 5.08.